NEXGEL (NASDAQ:NXGL – Get Free Report) is scheduled to be issuing its quarterly earnings data before the market opens on Wednesday, November 13th. Individual that wish to register for the company’s earnings conference call can do so using this link.
NEXGEL (NASDAQ:NXGL – Get Free Report) last announced its quarterly earnings results on Monday, August 19th. The company reported ($0.14) EPS for the quarter. NEXGEL had a negative net margin of 67.80% and a negative return on equity of 64.21%. The business had revenue of $1.44 million for the quarter.
NEXGEL Stock Performance
NXGL opened at $3.50 on Tuesday. NEXGEL has a 1-year low of $1.70 and a 1-year high of $3.55. The company has a market cap of $22.13 million, a price-to-earnings ratio of -6.14 and a beta of 0.73. The company’s fifty day moving average price is $2.78 and its two-hundred day moving average price is $2.52. The company has a current ratio of 1.36, a quick ratio of 0.81 and a debt-to-equity ratio of 0.22.
About NEXGEL
NEXGEL, Inc manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc and changed its name to NEXGEL, Inc in November 2019.
Read More
- Five stocks we like better than NEXGEL
- Following Congress Stock Trades
- Is Tesla’s Valuation a Bubble or Backed by Real Growth?
- Most Volatile Stocks, What Investors Need to Know
- Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?
- Ride Out The Recession With These Dividend Kings
- These 3 Active ETFs Beat the S&P 500 Over the Last Five Years
Receive News & Ratings for NEXGEL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NEXGEL and related companies with MarketBeat.com's FREE daily email newsletter.
